Zusammenfassung
Erhöhter Blutdruck bedeutet für den betroffenen Patienten ein erhöhtes Risiko, eine atherosklerotische Gefäßerkrankung mit allen damit verbundenen Risiken und Komplikationen zu erwerben (Goldbourt 1975, Kannel 1981). Die frühzeitige Erkennung und Behandlung einer Hypertonie sollte deshalb vitales Interesse des Patienten und vordringliche Aufgabe des Arztes sein und hat zusätzlich hohe sozialmedizinische Bedeutung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agner, E.: Predictive value of arterial blood pressure in old age. Acta med. Scand. 214: 285–294 (1983).
Amery, A., Hansson, L., Andren, L., Gudbrandsson, T., Sivertsson, R., Svensson, A.: Hypertension in the elderly. Acta med. Scand. 210: 221–229 (1981).
Ames, R. P., Peacock, P. B.: Semm cholesterol during treatment of hypertension with diuretic dmgs. Arch. Int. Med. 144: 710–714 (1984).
Anonymous: Dangerous antihypertensive treatment. Brit. Med. J. 2: 228–229 (1979).
Applegate, W. A., Dismuke, S. E., Runyan, J. W.: Treatment of hypertension in the elderly. J. Am. Geriatr. Soc. 32: 21–23 (1984).
Bayliss, J., Norell, M. S., Canepa-Anson, R., Reid, C., Poole-Wilson, P., Sutton, G.: Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of Captopril and prazosin. Brit. Med. J. 290: 1861–1865 (1985).
Bentley, D. W., Wilhams, M. E., Williams, T. F.: Hypertension in the elderly. J. Am. Geriatr. Soc. 30: 352–359 (1982).
Berglund, G., Andersson, O.: Beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects. Lancet i: 744–747 (1981).
Braunwald, E.: Mechanism of action of calcium-channel-blocking agents. New Engl. J. Med. 307: 1618–1627 (1982).
Brown, J. J., Lever, A. F., Robertson, J. I. S., Schalekamp, M. A.: Pathogenesis of essential hypertension. Lancet i: 1217–1221 (1976).
Bühler, F. R., Burkhart, F., Lüthold, B. E., Küng, M., Marbert, G., Pfisterer, M.: Antihypertensive beta-blocking action as related to renin and age: a pharmacological tool to identify pathogenetic mechanisms in essential hypertension. Am. J. Cardiol. 36: 653–669 (1975).
Bühler, F. R., deLeche, A. S., Schüler, G., Gutzwiller, F., Baumann, F., Schweizer, W.: Das Hypertonieproblem in der Schweiz. Schweiz. Med. Wschr. 106: 99–107 (1976).
Bühler, F. R.: Renin und Alter, Determinanten der Betabiocker-Wirkung beim essentiellen Hochdruck. In: Betablocker in der Hypertonie-Behandlung (Hitzenberger, G., Hrsg.), S. 42. München: Urban & Schwarzenberg 1976.
Bühler, F. R., Kiowski, W., van Brummelen, P., Amann, F. W., Bertel, O.: Abnahme der beta- adrenozeptorenvermittelten kardiovaskulären Funktionen und Zunahme der Alpha-rezep- torvermittelten Vasokonstriktion: Altersabhängige Verändemngen bei essentieller Hypertonie. Therapiewoche 30: 8298 (1980).
Charles, S., Ketelslegers, J.-M., Buysschaert, M., Lambert, A. E.: Hyperglycemic effect of nifedipin. Brit. Med. J. 283: 19–20 (1981).
Chobanian, A. V.: Therapeutic decision-makmg in systolic hypertension. Geriatrics 36/3: 36–43 (1981).
Cogan, E., Abramow, M.: Diuretic-induced hyponatremia in elderly hypertensive women. Lancet ii: 1249 (1983).
Cohn, J. N.: Blood pressure and cardiac performance. Am. J. Med. 55: 351–361 (1973).
Cove, D. H., Seddon, M., Fletcher, R. F., Dukes, D. C.: Blindness after treatment for malignant hypertension. Brit. Med. J. 2: 245–246 (1979).
Dahl, L. K., Heine, M., Thompson, K.: Genetic influence of the kidneys on blood pressure. Circuì. Res. 34: 94–101 (1974).
Diamond, J. R., Cheung, J. Y., Fang, L. S. T.: Nifedipine-induced renal dysfunction. Am. J. Med. 77:905–909 (1984).
Eliasson, K.: Borderline hypertension. Acta Med. Scand. Suppl. 692 (1985).
Feldman, R. D., Limbird, L. E., Nadeau, J., Robertson, D., Wood, A. J. J.: Alterations in leucocyte beta-receptor affinity with aging. New Engl. J. Med. 310: 815–819 (1984).
Ferrario, C. M., Gildenberg, P. L., McCullin, J. W.: Cardiovascular effects of angiotensin mediated by the central nervous system. Circuì. Res. 30: 257–262 (1972).
Fleisch, J. H., Hooker, C. S.: The relationship between age and relaxation of vascular smooth muscle in the rabbit and rat. Circuì. Res. 38: 243–249 (1976).
Freis, E. D.: Salt, volume and the prevention of hypertension. Circuì. 53: 589–595 (1976).
Gerstenbuth, G., Frederiksen, J., Yin, F. C. P., Fortuin, N. J., Lakatta, E. G., Weisfeldt, M. L.: Echocardiographic assessment of a normal adult aging population. Circulation 56: 273–278 (1977).
Goldbourt, U., Medalie, J. H., Neufeld, H. N.: Clinical myocardial infarction over a five-year period, in. A multivariate analysis of incidence, the Israel Ischemic Heart Disease Study. J. Chron. Dis. 28: 217–237 (1975).
Gradaus, D., Scheler, M., Möninghoff, W., Bender, F.: Röntgenologisch nachweisbare Herz- kranzgefaß-Verkalkungen bei über 65jährigen. Fortschr. Med. 98: 1019–1021 (1981).
Greminger, P., Vetter, W., Zimmermann, K., Beckerhoff, R., Siegenthaler, W.: Primäre und sekundäre Hypertonie in einem poliklinischen Krankengut. Schweiz, med. Wschr. 107: 605–609 (1977).
Gribbin, B., Pickering, T. G., Sleight, P., Peto, R.: Effect of age and high blood pressure on baroreflex sensitivity in man. Circuì. Res. 29: 424–431 (1971).
Haeriin, R., Bruckschen, E. G., Henze, F.: Antihypertensive Therapie mit Ebrantil Retardkapseln. Therapiewoche 31: 7930–7939 (1981).
Harburg, E., Erfurt, J. C., Chape, C., Hauenstein, L. S., Schull, W. J., Schork, M. A.: Socioecological stressor areas and black-white blood pressure: Detroit. J. Chron. Dis. 26: 595–611 (1973).
Hegstad, R., Brown, R. D., Jiang, N.-S., Kao, P., Weinshilboum, R.M., Strong, C., Wisgerhof, M.: Aging and aldosterone. Am. J. Med. 74: 442–448 (1983).
Heidland, A., Heidbreder, E., Hörl, W. H., Schäfer, R. M.: Calciumantagonisten in der Therapie der Hypertonie. Klin. Wschr. 61: 633–640 (1983).
Henry, P. D.: Comparative pharmacology of calcium antagonists: nifedipin, verapamil and diltiazem. Am. J. Cardiol. 46: 1047–1058 (1980).
Hunter Hypertension Research Goup. Changes in serum lipid levels during antihypertensive therapy. Med. J. Austral. 140: 522–524 (1984).
Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the hypertension detection and follow-up program (I, II). J.A.M.A. 242: 2562–2571, 2572–2577 (1979).
Izzo, J. L.: Hypertension in the elderly. J. Am. Geriatr. Soc. 30: 352–357 (1982).
Jackson, G., Pierscianowski, T. A., Mahon, W., Condon, J.: Inappropriate antihypertensive therapy in the elderly. Lancet ii: 1317–1318 (1976).
Kannel, W. B., Schwartz, M. J., McNamara, P. M.: Blood pressure and risk of coronary heart disease: the Framingham Study. Dis. Chest. 56: 43–52 (1969).
Kannel, W. B., Castelli, W. P., McNamara, P. M.: McKee, P. A., Feinleib, M.: Role of blood pressure in the development of congestive heart failure. New Engl. J. Med. 287: 781–787 (1972).
Kannel, W. B.: Some lessons in cardiovascular epidemiology from Framingham. Am. J. Cardiol. 37:269–282(1976).
Karmel, W. B., Dawber, T. R., McGee, D. L.: Perspectives on systolic hypertension: the Framingham Study. Circulation 61:1179–1182 (1980).
Kannel, W. B., Wolf, P. A., McGee, D. L., Dawber, T. R., McNamara, P., Casteui, W. P.: Systolic blood pressure, arterial rigidity, and risk of stroke. J. A. M. A. 245: 1225–1229 (1981).
Kirkendall, W. M., Hammond, J. J., Thomas, J. C., Overturf, M. L., Zama, A.: Prazosin and Clonidine for moderately severe hypertension. J. A.M. A. 240: 2553–2556 (1978).
Klein, G., Brugger, P.: Grenzwert-Hypertonie. Öst. Ärzteztg. 39: 884–888 (1984).
Komhuber, H. H., Lisson, G.: Bluthochdruck, Übergewicht und Alter: für Frühbehandlung der Hypertonie. Dtsch. Med.Wschr. 106: 1692–1696 (1981).
Lakatta, E. G., Yin, F. C. P.: Myocardial aging: functional alterations and related cellular mechanisms. Am. J. Physiol. 242: H927–941 (1982).
Lederballen-Pedersen, O., Mikkelsen, E., Christensen, N. J., Kornerup, H. J., Pedersen, E. B.: Effect of nifedipin on plasma renin, aldosterone and catecholamines in arterial hypertension. J. Clin. Pharm. 15: 235–240 (1979).
Leishman, A. W.: Merits of reducing high blood pressure. Lancet i: 1284–1288 (1963).
Leren, P., Foss, P. O., Helgeland, A., Hjermann, L, Holme, L, Lund-Larsen, P. G.: Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet ii: 4–6 (1980).
Libow, L. S., Butler, R. N.: Treating mild diastolic hypertension in the elderly: uncertain benefits and possible dangers. Geriatrics 36/11: 55–62 (1981).
Lindholm, L., Ejlertson, G., Schersten, B.: High rish cerebro-cardiovascular morbidity in well treated male hypertensives. Acta Med. Scand. 216: 251–259 (1984).
Linzbach, A. J., Akuamoa-Boateng, E.: Die Altersveränderungen des menschlichen Herzens. I. Das Herzgewicht im Alter. Klin. Wschr. 51: 156–163 (1973).
Management Committee of the Australian Hypertension Trial: The Australian therapeutic trial in mild hypertension. Lancet i: 1261–1267 (1980).
Management Committee of the Australian Therapeutic Trial in Mild Hypertension: Untreated mild hypertension. Lancet i: 185–191 (1982).
Mannmg, G. W., Smiley, J. R.: QRS-voltage criteria for left ventricular hypertrophy in a normal male population. Circuì. 29: 224–230 (1964).
McNair, A., Rasmussen, S., Nielsen, P. E., Rasmussen, K.: The antihypertensive effect of prazosin on mild to moderate hypertension, changes in plasma volume, extracellular volume and glomemlar filtration rate. Acta Med. Scand. 207: 413–416 (1980).
Medical Research Council Working Party on Mild to Moderate Hypertension: Adverse reactions to bendrofluazide and propranolol for the treatment of müd hypertension. Lancet ii: 539–543 (1981).
Messerli, F. H., Sundgaard-Riise, K., Ventura, H. O, Dunn, F. G., Glade, L. B., Fröhlich, E. D.: Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet ii: 983–986 (1983).
Michel, D.: Arterieller Blutdruck: In: Handbuch der Gerontologie (Platt, D., Hrsg.), Bd. 1, S. 129–150. Stuttgart: G. Fischer 1983.
Murphy, M. B., Lewis, P. J., Kohner, E., Schumer, B., Dollery, C. T.: Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet ii: 1293–1295 (1982).
Myers, M. G., Kearns, P. M., Kennedy, D. S., Fischer, R. H.: Postural hypotension and diuretic therapy in the elderly. Canad. Med. Ass. J. 119: 581–585 (1978).
National Health Survey: Hypertension and hypertensive heart disease in adults, U.S. 1960–62 (Vital Health Statistics Series 11, No. 13). Washington, D.C.: U.S. Department of Health, Education and Welfare 1966.
North, J. D. K., Williams, J. C. P., Howie, R. N.: Severe hypertension treated with ganglion- blocking drugs in a general hospital. Brit. Med. J. 1: 1426–1429 (1961).
O’Malley, K., O’Brien, E.: Management of hypertension in the elderly. New Engl. J. Med. 302: 1397–1401 (1980).
Ostfeld, A. M.: Elderly hypertensive patient. N. Y. State J. Med. 78: 1125–1129 (1978).
Poston, L., Sewell, R. B., Wilkinson, S. P., Richardson, P. J., Williams, R., Clarkson, E. M., MacGregor, G. A., de Wardener, H. E.: Evidence for a circulating sodium transport inhibitor in essential hypertension. Brit. Med. J. 282: 847–849 (1981).
Ram, C. V. S.: Hypertensive Encephalopathy. Arch. Int. Med. 138: 1851–1853 (1978).
Riozzi, A., Heagerty, A. M., Bing, R. P., Thruston, H., Swales, J. D.: Noradrenalin: a circulating inhibitor of sodium transport. Brit. Med. J. 289: 1025–1027 (1984).
Rowe, J. W.: Systolic hypertension in the elderly. New Engl. J. Med. 309: 1246–1247 (1983).
Rudolph, C. D., Kaplan, S. L., Ganong, W. P.: Sites at which Clonidine acts to affect blood pressure and the secretion of renin, growth hormone and ACTH. Neuroendocrinology 31: 121–128 (1980).
Russel, R. W. R.: How does blood-pressure cause stroke? Lancet ii: 1283–1285 (1975).
Scheler, P., Valentin, R.: Kritische Bemerkungen zur Hochdrucktherapie. Internist 25: 398–403 (1984).
Schettler, G.: Die Ätiologie der Arteriosklerose. Intemist 19: 611–620 (1978).
Schocken, D. D., Roth, G. S.: Reduced beta-adrenergic receptor concentrations in ageing man. Nature 267: 856–858 (1977).
Schoetensack, W., Bischler, P., Dittmann, Ch., Steinijans, V.: Tierexperimentelle Untersuchungen über den Einfluß des Antihypertensivums Urapidil auf den Kreislauf und die Kreislaufregulation. Arzneimittel Forsch. 27/2: 1908–1919 (1977).
Schwid, S. A., Gifford, R. W.: The use and abuse of antihypertensive drugs in the aged. Geriatrics 22/6: 172–182 (1967).
Schwietzer, G., Oelkers, W.: The antihypertensive effect of Captopril in severe essential, renovascular, renal and transplant renovascular hypertension. Klin. Wschr. 60: 839–846 (1982).
Sever, P. S., Gordon, D., Peart, W. J., Beighton,P.: Blood pressure and its correlates in urban and tribal Africa. Lancet ii: 60–64 (1980).
Simon, A. C., Safar, M. A., Levenson, J. A., Kheder, A. M., Levy, B. I.: Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment. Am. J. Cardiol. 44: 505–511 (1979).
Singer, R. B.: To treat or not to treat. J. Chron. Dis. 28: 125–134 (1975).
Skinhoj, E., Strandgaard, S.: Pathogenesis of hypertensive encephalopathy. Lancet i: 461–462 (1973).
Skrabal, F., Herholz, H., Neumayer, M., Hambergerr, L., Cerny, E.: Neues Konzept für die Entstehung der essentiellen Hypertonie. Dtsch. Med. Wschr. 108: 1122–1126 (1983).
Sokolow, M., Lyon, Th. P.: Ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am. Heart J. 37: 161–186 (1949).
Stamler, J., Stamler, R., Rhomberg, P., Dyer, A., Berkson, D. M., Reedus, W., Wannamaker, J.: Multivariate analysis of the relationship of sbc variables to blood pressure. J. Chron. Dis. 28: 499–525 (1975).
Stanek, B., Silberbauer, K.: Über die Altersabhängigkeit des Ansprechens von Blutdruck und Herzfrequenz sowie der Plasma-Renin-Aktivität auf Captopril bei essentieller Hypertonie. Acta Med. Austriaca 11: 101–105 (1984).
Strandgaard, S., Giesen, J., Skinhoj, E., Lassen, N. A.: Autoregulation of brain circulation in severe arterial hypertension. Brit. Med. J. 1: 507–510 (1973).
Strauer, B. E.: Hypertensive Heart Disease. Berlin-Heidelberg-New York: Springer 1980.
Studer, A., Lüscher, T., Greminger, P., Epstein, F. H., Grimm, J., Leumann, E. P., Tenschert, W., Siegenthaler, W., Vetter, W.: Blutdruck, Renin-Angiotensin-Aldosteron-System und andere kardiovaskuläre Risikofaktoren bei Kindern essentieller Hypertoniker. Klin. Wschr. 60: 275–284 (1982).
Stumpe, K. O., Kolloch, R., Vetter, H., Gramann, W., Krück, F., Ressel, Gh., Higuchi,M.: Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Am. J. Med. 60: 853–865 (1976).
Svärdsudd, K., Tibblin, G.: A longitudinal blood pressure study. Change of blood pressure during 10 years in relation to initial values. The study of men bom in 1913. J. Chron. Dis. 33:627–636 (1980).
Tarazi, R. C.: Should you treat systohc hypertension in elderly patients? Geriatrics 33/11: 25–29 (1978).
Tarazi, R. C.: The heart in hypertension. New Engl. J. Med. 312: 308–309 (1985).
Tjandramaga, T. B.: Altered pharmacokinetics of beta-adrenoceptor blocking dmgs in patients with renal insufficiency. Arch. Intern. Pharmacodyn. 243, Suppl. 38–53 (1980).
Topol, E. J., Traill, T. A., Fortuin, N. J.: Hypertensive hypertrophic cardiomyopathy of the elderly. New Engl. J. Med. 312: 277–283 (1985).
Verbeelen, D. L., De Boel, S.: Reversible acute on chronic renal failure during Captopril treatment. Brit. Med. J. 289: 20–21 (1984).
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. Resuhs in patients with diastolic blood pressure averaging 115 trough 129 mm Hg. J. A.M. A. 202: 1028–1034 (1967).
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. J. A.M. A. 213: 1143–1152 (1970).
Vetter, W., Webling, M., Foerster, E. Ch., Kuhlmann, U., Boerlin, H.-J., Greminger, P., Vetter, H.: Long-term effect of Captopril on kidney function in various forms of hypertension. Klin. Wschr. 62: 731–737 (1984).
Voelkel, O.: Alters- und geschlechtsspezifische Verteilung der Blutdmckwerte. Öst. Ärzteztg. 35/3: 137–146 (1980).
Voors, A. W., Berenson, G. S., Dalferes, E. R., Webber, L. S., Shuler, S. E.: Racial differences in blood pressure control. Science 204: 1091–1094 (1979).
Walter, U.: AT Pase Aktivität und Natriumtransport an Erythrozyten bei essentieller Hypertonie. Khn. Wschr. 60: 607–616 (1982).
Weidmann, P., deChatel, R., Schiffmann, A., Bachmann, E., Beretta-Piccoh, C., Reubi, F. C., Ziegler, W. H., Vetter, W.: Interrelations between age and plasma renin, aldosterone and Cortisol, urinary catecholamines, and the body sodium/volume state in normal man. Klin. Wschr. 55: 725–733 (1977).
Weinberger, M. H.: Antihypertensive threrapy and Hpids. Arch. Int. Med. 145: 1102–1105 (1985).
Wilhelmson, C., Vedin, J. A., Wilhelmsen, L., Tibblin, G.: Reduction of sudden death after myocardial infarction by treatment with alprenolol. Lancet ii: 1157–1160 (1974).
Woodcock, B. G., Rietbrock, N.: Beta-blocker induced changes in the cholesterol: high density lipoprotein cholesterol ratio and risk of coronary heart disease. Klin, Wschr. 62: 843–849 (1984).
Wu, M., Ware, J., Feinleib, M.: On the relation between blood-pressure change and initial value. J. Chron. Dis. 33: 627–636 (1980).
Yin, F. C. P.: The aging vasculature and its effects on the heart. In: The Aging Heart (Weisfeldt, M. L., Hrsg.), S. 137–213. New York: Raven Press 1980.
Ziegler, M. G., Lake, C. R., Kopin, I. J.: Plasma noradrenalin increases with age. Nat. 261: 333–335 (1976).
Anonymous: Dangerous antihypertensive treatment. Brit. Med. J. 2: 228–229 (1979).
Bannister, R.: Chronic autonomic failure with postural hypotension. Lancet ii: 404–406 (1979).
Barbey, K., Barbey, P.: Die Blutverschiebung in die untere Extremität bei der akuten orthostatischen Kreislaufbelastung. Med. Weh 17: 1693–1698 (1966).
Böhm, C.: Hypotonie und orthostatisches Syndrom. Krankheitswert und Therapie aus der Sicht der Praxis. Intemist 14: 511–520 (1973).
Brähler, E., Köhl, A., Lademann, H.-R.: Aspekte des Krankheitsverhaltens in der Bundesrepublik Deutschland. Med. WeU 30: 723–727 (1979).
Caird, F. I., Andrews, G. R., Kennedy, R. D.: Effect of posture on blood pressure in the elderly. Brit. Heart J. 35: 527–530 (1973).
Carter, A. B.: The neurologic aspects of aging. In: Clinical Geriatrics (Rossman, I., Hrsg.), S. 292. Philadelphia: Lippincott 1979.
Chobanian, A. V., Volicer, L., Tift, Ch. P., Gavras, H., Liang, C.-S., Faxon, D.:Mineralocorticoid-induced hypertension m patients with orthostatic hypotension. New Engl. J. Med. 301: 68–73 (1979).
Davies, B., Bannister, R., Sever, P.: Pressor amines and mono amine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Neurology 31: 1–7 (1981).
Delius, L.: Die Behandlung der hypotonen Kreislaufstömng. Dtsch. Med. Wschr. 94: 2172–2173 (1969).
De Marees, H., Jarmatz, H.: Blutvolumenverlagerung während orthostatischer Belastung unter oral appliziertem Dihydroergotamin. Münch. Med. Wschr. 119: 1301–1304 (1977).
Falck, L: Die Bedeutung von Stürzen in der Geriatrie. Zschr. Gerontol. 16: 254–259 (1983).
Gordon, R. D., Küchel, O., Liddle, G. W., Island, D. P.: Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J. Gin. Invest. 46: 599–605 (1967).
Gribbin, B., Pickering, T. G., Sleight, P., Peto, R.: Effect of age and high blood pressure on baroreflex sensitivity in man. Circuì. Res. 29: 424–431 (1971).
Hamlin, J. T., Hickler, R. B., Hoskins, R. G.: Free fatty acid mobilization by neuroadrenergic stimulation in man. J. Clin. Invest. 39: 606–609 (1960).
Heinrich, F.: Medikamentöse und physikalische Therapie der Hypotonie. Internist 14: 525–530 (1973).
Hengstmann, J.: Metabolie pattern and pharmacokinetic properties of phenolic sympathico- mimetic amines. Arzneimittel-Forsch. 26: 1251 (1976).
Hickler, R. B.: Orthostatic hypotension and syncope. New Engl. J. Med. 296: 336–337 (1977).
Hines, S., Houston, M., Robertson, D.: The clinical spectrum of autonomic dysfunction. Am. J.Med. 70: 1091–1096 (1981).
Horie, H., Hanafusa, T., Matsuyama, T., Namba, M., Nonaka, K., Tarui, S., Yamatodani, A., Wada, H.: Decreased response of epinephrine and norepinephrine to insulin-induced hypoglycemia in diabetic autonomic neuropathy. Horm. Metab. Res. 16: 398–401 (1984).
Hui, K. K. P., Conolly, M. E.: Increased numbers of beta receptors in orthostatic hypotension due to autonomic dysfunction. New Engl. J. Med. 304: 1473–1476 (1981).
Jackson, G., Pierscianowski, T. A., Mahon, W., Condon, J.: Inappropriate antihypertensive therapy in the elderly. Lancet ii: 1317–1318 (1976).
Kochar, M. S., Itskovitz, H. D.: Treatment of idiopathic orthostatic hypotension (Shy-Drager Syndrome) with indomethacin. Lancet i: 1011–1014 (1978).
Kontos, H. A., Richardson, D. W., Norvell, J. E.: Norepinephrine depletion in idiopathic orthostatic hypotension. Ann. Int. Med. 82: 336–341 (1975).
Lang, E.: Die orthostatische Hypotonie bei älteren Menschen. Cardiology 61 (Suppl. 1): 225–235 (1976).
Leaf, A.: Dehydration in the elderly. New Engl. J. Med. 311: 791–792 (1984).
Lima, J. A. C., Weiss, J. L., Guzman, P. A., Weisfeldt, M. L., Reid, P. R., Traill, T. A.: Incomplete filling and incoordinate contraction as mechanisms of hypotension during ventricular tachycardia in man. Circulation 68: 928–938 (1983).
Lindner, E.: Wirkung vasopressorischer Substanzen auf die Gefäßwand. Med. Welt 26: 1017–1024 (1975).
Lipsitz, L. A.: Syncope in the elderly. Ann. Int. Med. 99: 92–105 (1983).
Lipsitz, L. A., Nyquist, R. P., Wei, J. Y., Rowe, J. W.: Postprandial reduction in blood pressure in the elderly. New Engl. J. Med. 309: 81–83 (1983).
Massie, B., Kramer, B., Haughom, F.: Postural hypotension and tachycardia during hydralazin-isosorbide dinitrate therapy for chronic heart faüure. Circulation 63: 658–664 (1981).
Meilander, S., Nordenfeldt, I.: Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation. Clin. Sci. 39: 183–201 (1970).
Mitchinson, M. J.: The hypotensive stroke. Lancet i: 244–246 (1980).
Muth, H. H., Jansen, W.: Dihydergot plus zur Langzeittherapie hypotoner orthostatischer Dysregulationen bei älteren Patienten. Fortschr. Med. 98: 1571–1574 (1980).
Myers, M. G., Kearns, P. M., Kennedy, D. S., Fischer, R. H.: Postural hypotension and diuretic therapy in the elderly. Cañad. Med. Ass. J. 119: 581–585 (1978).
Nanda, R. N., Johnson, R. H., Keogh, H. J.: Treatment of neurogenic orthostatic hypotension with a monoamine oxidase inhibitor and tyramine. Lancet ii: 1164–1167 (1976).
Polinsky, R. J., Kopin, L J., Ebert, M. E., Weise, U.: Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 31: 1–7 (1981).
Rieckert, H.: Die Kreislaufregulation bei jungen Sportlern unter orthostatischer Belastung. Med. Weh 23: 362–365 (1972).
Rieckert, H.: Hypotonie. Berlin-Heidelberg-New York: Springer 1979.
Robertson, D., Wade, D., Robertson, R. M.: Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunctional states. Am. J. Cardiol. 48: 1048–1052 (1981).
Robertson, D., Goldberg, M. R., Hollister, A. S., Wade, D., Robertson, R. M.: Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am. J. Med. 74: 193–200 (1983).
Rode, P., Heinrich, F., Voegt, H.: Auswirkungen der Beta-Rezeptorenblockade auf Systolen- dauer und Temporahskurve unter Orthostasebedingungen. Med. Weh 22: 1733–1737 (1971).
Sheps, S. G.: Use of an elastic garment in the treatment of orthostatic hypotension. Cardiology 61 (Suppl. 1): 271–279 (1976).
Shoukas, A. A., Sagawa, K.: Control of total systemic vascular capacity by the carotid sinus baroreceptor reflex. Circuì. Res. 33: 22–33 (1973).
Steen, B., Lundgren, B. K., Isaksson, B.: Body water in the elderly. Lancet i: 101 (1985).
Stürmer, E.: Pharmacologic basis of the treatment of orthostatic disorders with ergot alkaloids. Cardiology 61 (Suppl. 1): 290–301 (1976).
Thulesius, O., Ferner, U.: Diagnose der orthostatischen Hypotonie. Zschr. f. Kreislauffschg. 61:742–754 (1972).
Thulesius, O.: Pathophysiological classification and diagnosis of orthostatic hypotension. Cardiology 61 (Suppl. 1): 180–190 (1976).
Tiso, B.: Orthostasesyndrom. Wien. Klin.Wschr. 89: 69–76 (1977).
Volk, W.: Hypotone Kreislaufregulationsstörung unter Psychopharmakamedikation. Med. Weh 28: 1853–1854 (1977).
Westermann, K. W.: Pathophysiologische Grundlagen der Hypotonie. Internist 14: 483–490 (1973).
White, N. J.: Heart-rate changes on standing m elderly patients with orthostatic hypotension. Clin. Sci. 58: 411–413 (1980).
Widmer, L. K.: Venenkrankheiten, Häufigkeit und sozialmedizinische Bedeutung. Beobachtung bei 4529 anscheinend gesunden Berufstätigen. (Basler Studie III.) Bem: Huber 1978.
Yin, F. C. P., Raizes, G. S., Guamieri, T., Spurgeon, H. A., Lakatta, E. G., Fortuin, N. J., Weisfeldt, M. L. : Age-associated decrease in ventricular response to a hemodynamic stress during beta-adrenergic blockade. Brit. Heart J. 40: 1349–1355 (1978).
Ziegler, M. G., Lake, C. R., Kopin, I. J.: The sympathetic-nervous-system defect in primary orthostatic hypotension. New Engl. J. Med. 296: 293–297 (1977).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag/Wien
About this chapter
Cite this chapter
Tragl, K.H. (1986). Der Blutdruck im höheren Lebensalter. In: Internistische Geriatrie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8839-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8839-2_4
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-81904-3
Online ISBN: 978-3-7091-8839-2
eBook Packages: Springer Book Archive